Secondary1st is delighted to announce that, thanks to our wonderful donors and fundraisers, we have made a grant to fund a post-doctoral researcher in a new project run by Professor Seth Coffelt at the Beatson Institute for Cancer Research at the University of Glasgow. This new project follows previous research funded by Secondary1st which identified gamma delta T (gdT) cells which have the potential to become the target of a new immunotherapy treatment for triple negative breast cancer. Immunotherapy works by reprogramming the immune system to recognise and destroy cancer cells and so prevent them spreading to form secondary or metastatic tumours. The new project will investigate whether immunotherapies can be developed to boost the ability of gamma delta T cells to kill breast cancer cells and so achieve a better understanding of how they work to make sure that they are as safe and effective as possible, leading to the development of better targeted treatments.